Globus Medical, Inc. Class A (GMED) earnings
GMED earnings moved a median of +0.48% by the close. Quarterly and annual GMED reports and results, each read against the price at its own news timestamp. Back to the GMED overview →
35 measured GMED earnings events.
Where these GMED earnings landedvs 35 measured GMED earnings reactions
| Middle 50% of GMED earnings reactions | -2.79% to +2.63% |
|---|---|
| Median reaction (to close) | +0.48% |
| Measured reactions | 35 |
Point-in-time · zero look-ahead
Half of the 35 GMED earnings events with a measured close landed between -2.79% and +2.63%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Globus Medical Schedules Third Quarter Earnings Release and Conference Call | Press release | -0.03% | -0.49% | |
| Form 10-Q GLOBUS MEDICAL INC For: Jun 30 | SEC filing · Form 10-Q | -0.23% | -1.57% | |
| Globus Medical Reports Second Quarter 2026 Results | Press release | -0.23% | -1.57% | |
| Globus Medical Schedules Second Quarter Earnings Release and Conference Call | Press release | -2.01% | -4.63% | |
| Form 10-Q GLOBUS MEDICAL INC For: Mar 31 | SEC filing · Form 10-Q | -3.16% | -6.24% | |
| Globus Medical Reports First Quarter 2026 Results | Press release | -3.16% | -6.24% | |
| Globus Medical Schedules First Quarter Earnings Release and Conference Call | Press release | -0.09% | +1.25% | |
| Form 10-K GLOBUS MEDICAL INC For: Dec 31 | SEC filing · Form 10-K | +1.25% | +2.58% | |
| Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call | Press release | +1.03% | +0.94% | |
| Form 10-Q GLOBUS MEDICAL INC For: Sep 30 | SEC filing · Form 10-Q | +0.14% | +3.57% | |
| Globus Medical Reports Third Quarter 2025 Results | Press release | +0.14% | +3.57% | |
| Globus Medical Schedules Third Quarter Earnings Release and Conference Call | Press release | +0.02% | +1.55% | |
| Form 10-Q GLOBUS MEDICAL INC For: Jun 30 | SEC filing · Form 10-Q | +4.06% | +4.73% | |
| Globus Medical Reports Second Quarter 2025 Results | Press release | +4.06% | +4.73% | |
| Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results | Press release | -0.90% | -2.75% | |
| Globus Medical Schedules Second Quarter Earnings Release and Conference Call | Press release | -0.10% | -2.83% | |
| Form 10-Q GLOBUS MEDICAL INC For: Mar 31 | SEC filing · Form 10-Q | -5.00% | -7.21% | |
| Globus Medical Reports First Quarter 2025 Results | Press release | -5.00% | -7.21% | |
| Globus Medical Schedules First Quarter Earnings Release and Conference Call | Press release | +0.44% | -1.69% | |
| Form 10-K GLOBUS MEDICAL INC For: Dec 31 | SEC filing · Form 10-K | +0.73% | +0.04% | |
| Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call | Press release | -0.77% | -0.91% | |
| Form 10-Q GLOBUS MEDICAL INC For: Sep 30 | SEC filing · Form 10-Q | +4.89% | +3.36% | |
| Globus Medical Reports Third Quarter 2024 Results | Press release | +4.89% | +3.36% | |
| Globus Medical Schedules Third Quarter Earnings Release and Conference Call | Press release | +0.87% | +0.69% | |
| Form 10-Q GLOBUS MEDICAL INC For: Jun 30 | SEC filing · Form 10-Q | -1.68% | -3.86% | |
| Globus Medical Reports Second Quarter 2024 Results | Press release | -1.68% | -3.86% | |
| Globus Medical Schedules Second Quarter Earnings Release and Conference Call | Press release | +0.20% | +0.70% | |
| Form 10-Q GLOBUS MEDICAL INC For: Mar 31 | SEC filing · Form 10-Q | +3.80% | +3.75% | |
| Globus Medical Reports First Quarter 2024 Results | Press release | +3.80% | +3.75% | |
| Globus Medical Schedules First Quarter Earnings Release and Conference Call | Press release | +0.17% | -1.04% | |
| Form 10-K GLOBUS MEDICAL INC For: Dec 31 | SEC filing · Form 10-K | +4.95% | +2.69% | |
| Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call | Press release | -0.62% | +0.48% | |
| Form 10-Q GLOBUS MEDICAL INC For: Sep 30 | SEC filing · Form 10-Q | +0.74% | +1.17% | |
| Globus Medical Reports Third Quarter 2023 Results | Press release | +0.74% | +1.17% | |
| Globus Medical Schedules Third Quarter Earnings Release and Conference Call | Press release | -0.90% | -4.27% |
Keep exploring
More GMED: analyst actions → · SEC filings → · GMED overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| IMMUNE DESIGN CORP COMMON STOCK (IMDZ) | 432 | -0.12% | 43% |
| CRH MEDICAL CORP (CRHM) | 431 | 0.00% | 39% |
| SCYNEXIS, Inc. (SCYX) | 431 | 0.00% | 41% |
| LeMaitre Vascular, Inc. (LMAT) | 430 | +0.05% | 54% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.